http://orcid.org/0000-0002-7459-584X
References
- Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990;17:495–507.
- Liatsikos E, Kyriazis I, Kallidonis P, et al. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options. Aging Male. 2011;14:141–149.
- Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5:212–218.
- Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989;141:243.
- Chapple CR. The total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management: introduction and conclusions. Eur Urol. 2003;2:1–5.
- Singam P, Hong GE, Ho C, et al. Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice. Aging Male. 2015;18:112–117.
- Bardoli AD, Taylor WSJ, Mahmalji W. Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. Aging Male. 2017;20:192–197.
- Suijlekom HA, Lame I, Suzanne GM, et al. Quality of life patient with cervicogenic headache: a comparison with control subjects and patients with migraine or tension-type headache. Headache. 2003;43:1034–1041.
- Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I: applications and issues in assessment. BMJ. 1992;305:1074–1077.
- Kocyiğit H, Aydemir O, Fisek G, et al. Validity and reliability of Turkish version of Short Form 36: a study of a patient romatoid disorder. Drug Ther. 1999;12:102–106.
- Pınar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res. 2015;14:259–264.
- Demiral Y, Ergor G, Unal B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006;6:247.
- Yoshimura K, Utsunomiya N, Ichioka K. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology. 2005;65:290–294.
- Büker B, Koç S, Tuncay ÖL, et al. Transüretral Prostat Rezeksiyonu Sonrasında Erken Dönem Yaşam Kalitesindeki Değişiklikler [Changes in Early Life Quality after Transurethral Resection of the Prostate]. J Kartal TR. 2014;25:220–224. Turkish.
- Lee YJ, Oh SA, Kim SH, et al. Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study. PLoS One. 2017;12:e0182230.
- Rigatti L, Naspro R, Salonia A, et al. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology. 2006;67:1193–1198.
- Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109:408–411.
- Kuntz R, Lehrich K, Ahyai S. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–166.
- Pedraza A, Auladell A, Baena FG, et al. Quality of life of patients with benign prostatic hyperplasia (BPH): endoscopic surgery versus laser therapy. Arch Esp Urol. 2014;67:823–830.
- Jones P, Alzweri L, Rai BP, et al. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol. 2016;14:50–58.
- Gu X, Strom K, Spaliviero M, et al. Does age affect the efficacy and safety of GreenLight HPS™ laser photoselective vaporization prostatectomy? Aging Male. 2012;15:63–67.